title: Human papillomavirus-positive oral cavity and oropharyngeal cancer patients do not have better quality-of-life trajectories.
abstract: OBJECTIVE
  To determine the role of human papillomavirus (HPV) status on quality of life (QOL) in patients with oral cavity and oropharyngeal squamous cell carcinoma (OSCC). Since OSCC that are associated with high-risk HPV have an improved response to treatment and survival, we hypothesized that patients with these tumors would have better QOL trajectories.
  
  
  METHODS
  Prospective cohort study.
  
  
  METHODS
  Tertiary care academic medical center and 2 affiliated hospitals.
  
  
  METHODS
  Head and neck-specific QOL was determined using the University of Washington Quality of Life scale version 4 in patients with newly diagnosed invasive OSSC (N = 228).
  
  
  RESULTS
  Pretreatment QOL was higher in patients with high-risk HPV-associated tumors compared with patients with HPV-negative or low-risk HPV-associated tumors (P = .015). Patients with high-risk HPV-associated tumors had larger decreases in QOL from pretreatment to immediate posttreatment compared with patients with HPV-negative or low-risk HPV-associated tumors (P = .041). There was no association between HPV status and 1-year posttreatment QOL.
  
  
  CONCLUSIONS
  Among OSCC patients, high-risk HPV-associated tumors were associated with higher pretreatment QOL and a larger decrease in QOL from pretreatment to immediate posttreatment, suggesting that treatment intensity in this unique population may adversely affect QOL.
authors.affiliation: Department of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle, Washington, USA.
authors.forename: Arun
authors.initials: A
authors.lastname: Sharma
authors.forename: Eduardo
authors.initials: E
authors.lastname: Méndez
authors.forename: Bevan
authors.initials: B
authors.lastname: Yueh
authors.forename: Pawadee
authors.initials: P
authors.lastname: Lohavanichbutr
authors.forename: John
authors.initials: J
authors.lastname: Houck
authors.forename: David R
authors.initials: DR
authors.lastname: Doody
authors.forename: Neal D
authors.initials: ND
authors.lastname: Futran
authors.forename: Melissa P
authors.initials: MP
authors.lastname: Upton
authors.forename: Stephen M
authors.initials: SM
authors.lastname: Schwartz
authors.forename: Chu
authors.initials: C
authors.lastname: Chen
mesh_terms: D005260:Female; D006801:Humans; D016014:Linear Models; D008297:Male; D008875:Middle Aged; D009062:Mouth Neoplasms / Q000628:therapy / Q000821:virology*; D009361:Neoplasm Invasiveness; D009959:Oropharyngeal Neoplasms / Q000628:therapy / Q000821:virology*; D030361:Papillomavirus Infections / Q000150:complications* / Q000628:therapy; D011446:Prospective Studies; D011788:Quality of Life; D018709:Statistics, Nonparametric; D011795:Surveys and Questionnaires